Physician profile
Hemang H Shah
NPI 1982654042
$5,062.37
in general payments reported to CMS, 2019-2025
15 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $164 · 2021: $359 · 2022: $892 · 2023: $2,646 · 2024: $424 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,869 · Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,868.69 |
| Food and Beverage | $1,538.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,063.08 | 2022-2025 | Inspire |
| Zoll Respicardia, INC. | $1,122.31 | 2023 | Remede System |
| Jazz Pharmaceuticals INC. | $576.33 | 2019-2022 | |
| Harmony Biosciences LLC | $428.18 | 2020-2025 | |
| Fisher & Paykel Healthcare INC | $192.32 | 2024-2025 | Fisher & Paykel Healthcare |
| Horizon Therapeutics Plc | $122.30 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $119.46 | 2021 | |
| Abbvie INC. | $105.79 | 2021-2025 | Botox, Ubrelvy |
| Axsome Therapeutics, INC. | $105.21 | 2023-2024 | Sunosi |
| 3b Medical, INC. | $74.36 | 2025 | Luna |
| Resmed Corp | $48.21 | 2020-2025 | |
| Philips North America LLC | $37.87 | 2020-2023 | |
| Allergan, INC. | $35.76 | 2019-2020 | |
| Eisai INC. | $17.47 | 2021 | |
| Itamar Medical INC | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemang Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.